Tyler B. Tarr

496 total citations
14 papers, 317 citations indexed

About

Tyler B. Tarr is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tyler B. Tarr has authored 14 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Neurology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tyler B. Tarr's work include Myasthenia Gravis and Thymoma (7 papers), Ion channel regulation and function (7 papers) and Autoimmune Neurological Disorders and Treatments (5 papers). Tyler B. Tarr is often cited by papers focused on Myasthenia Gravis and Thymoma (7 papers), Ion channel regulation and function (7 papers) and Autoimmune Neurological Disorders and Treatments (5 papers). Tyler B. Tarr collaborates with scholars based in United States, Australia and China. Tyler B. Tarr's co-authors include Stephen D. Meriney, Peter Wipf, Markus Dittrich, David Lacomis, Thomas A. Blanpied, Stephen Reddel, Toni Schneider, Richard G. Held, Arn M. J. M. van den Maagdenberg and Changliang Liu and has published in prestigious journals such as Nature Communications, Neuron and Journal of Neuroscience.

In The Last Decade

Tyler B. Tarr

14 papers receiving 312 citations

Peers

Countries citing papers authored by Tyler B. Tarr

Since Specialization

Citations

This map shows the geographic impact of Tyler B. Tarr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler B. Tarr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler B. Tarr more than expected).

Fields of papers citing papers by Tyler B. Tarr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler B. Tarr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler B. Tarr. The network helps show where Tyler B. Tarr may publish in the future.

Co-authorship network of co-authors of Tyler B. Tarr

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler B. Tarr. A scholar is included among the top collaborators of Tyler B. Tarr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler B. Tarr. Tyler B. Tarr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABAAR subsynaptic reorganization 2025 ·Frontiers in Cellular Neuroscience ·Caitlyn A. Chapman, Nadya Povysheva, Tyler B. Tarr, (unknown), Stephen D. Meriney, Jon W. Johnson, Tija C. Jacob	1
2	Multiplexed expansion revealing for imaging multiprotein nanostructures in healthy and diseased brain 2024 ·Nature Communications ·Jinyoung Kang, (unknown), Young-Mi Lee, (unknown), Eunah Yu, Tyler B. Tarr, (unknown), Menglong Zeng, Demian Park, (unknown), Donglai Wei, Guoping Feng, Edward S. Boyden	2
3	Simulations of active zone structure and function at mammalian NMJs predict that loss of calcium channels alone is not sufficient to replicate LEMS effects 2023 ·Journal of Neurophysiology ·(unknown), Yomna Badawi, Rozita Laghaei, (unknown), (unknown), Tyler B. Tarr, (unknown), Stephen Reddel, Stephen D. Meriney	4
4	Revealing nanostructures in brain tissue via protein decrowding by iterative expansion microscopy 2022 ·Nature Biomedical Engineering ·Deblina Sarkar, Jinyoung Kang, Asmamaw T. Wassie, (unknown), Zhuyu Peng, Tyler B. Tarr, Ai‐Hui Tang, (unknown), Jennie Z. Young, Hanquan Su, Demian Park, Peng Yin, Li‐Huei Tsai, Thomas A. Blanpied, Edward S. Boyden	47
5	Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States 2022 ·Biomolecules ·(unknown), Yomna Badawi, Tyler B. Tarr, Stephen D. Meriney	6
6	Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry 2020 ·Neuron ·Richard G. Held, Changliang Liu, (unknown), (unknown), Tyler B. Tarr, Giovanni de Nola, Shan Shan H. Wang, Jie‐Xin Wang, Arn M. J. M. van den Maagdenberg, Toni Schneider, Jianyuan Sun, Thomas A. Blanpied, Pascal S. Kaeser	62
7	Transmitter release site organization can predict synaptic function at the neuromuscular junction 2017 ·Journal of Neurophysiology ·Rozita Laghaei, Jun Ma, Tyler B. Tarr, (unknown), Lauren S. Kelly, (unknown), (unknown), (unknown), Stephen D. Meriney, Markus Dittrich	22
8	Lambert–Eaton myasthenic syndrome: mouse passive‐transfer model illuminates disease pathology and facilitates testing therapeutic leads 2017 ·Annals of the New York Academy of Sciences ·Stephen D. Meriney, Tyler B. Tarr, (unknown), (unknown), Yi‐Zhi Li, David Lacomis, Adolfo Garcı́a-Ocaña, (unknown), (unknown), Peter Wipf	12
9	Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome 2014 ·Molecular Neurobiology ·Tyler B. Tarr, Peter Wipf, Stephen D. Meriney	29
10	Complete reversal of Lambert–Eaton myasthenic syndrome synaptic impairment by the combined use of a K⁺ channel blocker and a Ca²⁺ channel agonist 2014 ·The Journal of Physiology ·Tyler B. Tarr, David Lacomis, Stephen Reddel, (unknown), (unknown), (unknown), Peter Wipf, Stephen D. Meriney	23
11	Evaluation of a Novel Calcium Channel Agonist for Therapeutic Potential in Lambert-Eaton Myasthenic Syndrome 2013 ·Journal of Neuroscience ·Tyler B. Tarr, Waqas Malick, (unknown), (unknown), (unknown), David Lacomis, Stephen Reddel, (unknown), Peter Wipf, Stephen D. Meriney	37
12	New calcium channel agonists as potential therapeutics in Lambert–Eaton myasthenic syndrome and other neuromuscular diseases 2012 ·Annals of the New York Academy of Sciences ·Tyler B. Tarr, (unknown), (unknown), Peter Wipf, Stephen D. Meriney	9
13	Are unreliable release mechanisms conserved from NMJ to CNS? 2012 ·Trends in Neurosciences ·Tyler B. Tarr, Markus Dittrich, Stephen D. Meriney	42
14	Synthesis and Biological Evaluation of a Selective N- and P/Q-Type Calcium Channel Agonist 2012 ·ACS Medicinal Chemistry Letters ·(unknown), Tyler B. Tarr, Karla Bravo‐Altamirano, (unknown), (unknown), (unknown), Nicholas R. DeStefino, (unknown), (unknown), Gabriela Mustata Wilson, Stephen D. Meriney, Peter Wipf	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact